VEGFR-2 inhibitors (Novartis Institutes for BioMedical Research)

N/A

Report date: 2025/06/11 10:29:21
NME

Base Information

Drug NameVEGFR-2 inhibitors (Novartis Institutes for BioMedical Research)
Drug Alias NameDB-83-LM4UF-61-QB443
ClassificationSmall molecules
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonists
TargetsVascular endothelial growth factor receptor 2
Therapy Area/IndicationsChoroidal Neovascularization
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Institutes For Biomedical Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Institutes For Biomedical Research Inc
Inactive CompaniesN/A
Active IndicationsChoroidal Neovascularization
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A